Evonik's BioTechDay presents that "white biotechnology" has above-average growth prospects
Nearly 200 participants learned about what biotechnology can do for the chemical industry
The use of renewable raw materials presents special opportunities and prospects
Without it, we would have no beer, no bread, no wine, and no yogurt. We're talking about "white biotechnology. "It’s the lever of nature, as it were, and is used in the production of these and many other products. Microorganisms and enzymes have been performing this task for thousands of years, so today we cannot imagine the chemical industry without white biotechnology either. Also called "industrial biotechnology," it provides new approaches to manufacturing novel products with useful properties, or to manufacturing, for example, polymer building blocks and active ingredients by entirely different means. Because it is highly energy- and resource-efficient, white biotechnology is often an alternative to conventional chemical processes. Especially in the health, nutrition, and cosmetic markets, there are constantly new growth opportunities for bio-based products. Evonik's BioTechDay has clearly shown that white biotechnology has above-average growth prospects.
Some 200 participants from the Group as well as from business and government met for this event on March 9 and 10, 2011, in Marl in the spirit of "Superior growth through biotechnology." Evonik itself has special expertise in developing strains, in fermentation, and in processing bioproducts. Evonik is thus well-positioned in those areas that are relevant to industrial biotechnology.
Besides the economic growth opportunities through biotechnology, the event also centered around "renewable resources." The backdrop for this topic is the changing raw materials supply. Patrik Wohlhauser and Dr. Thomas Haeberle from Evonik Degussa GmbH and Dr. Peter Nagler, who heads Innovation Management Chemicals & Creavis at Evonik, and the managers of several business units offered their assessments of the situation. In his remarks, Wohlhauser emphasized the high growth rates of today's biotechnology segment at Evonik and called for further efforts to generate sustainable growth on the way the company has already paved. Dr. Nagler underlined the prominent role that white biotechnology plays in Evonik's innovation portfolio, and which will figure even more prominently in the future.
Moreover, various representatives from international corporations such as Cargill or Dupont presented their views on the changing supply of raw materials and on future innovative products of industrial biotechnology. In this regard, Ray Miller, Dupont's global business development manager, described the evolution of his chemical corporation from a company that used to be involved in manufacturing explosives to a forerunner in specialty chemicals that is geared effectively to biotechnology.
As part of a product marketplace, classic bio-based products such as amino acids and cosmetic active ingredients were presented, as were Evonik's new innovative developments that have already established themselves on the market.
"With Evonik BioTechDay, we're building bridges between our present businesses and future innovative biotechnology-based products and processes. Second, we're responding to current developments such as changing raw materials scenarios, too, and the resulting high-growth business models," said Dr. Thomas Haas, head of the Biotechnology Science-to-Business Center.
About Creavis Technologies & Innovation
As the strategic research and development unit of the Chemicals Business Area at Evonik, Creavis has the mission of building new and sustainable business for Evonik and develop forward-looking technology platforms. Creavis’ job is focussed on new technologies, applications and systems for the markets of the future, promising above-average growth rates. Depending on the risk of the research topic, they are dealt with either in socalled Project Houses or Science-to Business-Centers. Visit us at http://www.evonik.com/creavis
Evonik Industries is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company’s performance is shaped by creativity, specialization, continuous self-renewal, and reliability.
Evonik is active in over 100 countries around the world. In its fiscal year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.